Treatment Options in Advanced Myelodysplastic Syndrome, with Emphasis on Epigenetic Therapy

スポンサーリンク

概要

• 論文の詳細を見る
• 2007-11-15

著者

• OKI Yasuhiro

  Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital

• ISSA Jean-Pierre

  Department of Leukemia, University of Texas M. D. Anderson Cancer Center

• Issa Jean-pierre

  Department Of Leukemia University Of Texas M. D. Anderson Cancer Center

• Oki Yasuhiro

  Department Of Hematology And Cell Therapy Aichi Cancer Center

関連論文

• Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
• Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas
• Treatment Options in Advanced Myelodysplastic Syndrome, with Emphasis on Epigenetic Therapy
• High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma

スポンサーリンク